Centene Corporation

465 articles with Centene Corporation

• Health Net Federal Services, LLC Earns URAC Accreditations In Health Utilization, Case And Disease Management

  1/6/2021

  Health Net Federal Services, LLC, a wholly owned subsidiary of Centene Corporation, announced it has earned URAC accreditations in Health Utilization Management, Case Management and Disease Management.

• Centene Signs Definitive Agreement to Acquire Magellan Health

  1/4/2021

  Acquisition will broaden and deepen Centene's whole health capabilities, while establishing a leading behavioral health platform at a critical time

• Centene To Present At Virtual JP Morgan 39th Healthcare Conference

  12/31/2020

   Centene Corporation (NYSE: CNC) announced today it will present at the virtual 39 th Annual J.P. Morgan Healthcare Conference, to be held January 11-14, 2021 . Centene will participate in a virtual format on Monday, January 11 th at 9:10 a.m. Eastern Standard Time (EST). A simultaneous live audio webcast is available at: ht

• Centene Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx)

  12/30/2020

  Centene Corporation (NYSE: CNC) today announced that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases. "We are pleased to welcome the PANTHERx team to the Centene family," said Michael F. Neido

• Centene Corporation Announces 2021 Guidance

  12/18/2020

  Centene Corporation announced its 2021 financial guidance. Total revenues are expected to be $114.1 billion to $116.1 billion, and diluted earnings per share are expected to be $3.82 to $4.06.

• Diameter Health Closes $18M Series B to Accelerate Vision to Improve Health Data Interoperability

  12/17/2020

  Diameter Health, a fast-growing leader in health data interoperability, has announced that it raised $18 million in a Series B funding round led by managed care organization Centene Corporation, with participation from existing investors Optum Ventures, LRVHealth, Connecticut Innovations and Activate Venture Partners.

• Centene Signs Definitive Agreement to Acquire PANTHERx Rare Pharmacy (PANTHERx)

  12/15/2020

  Centene Corporation announced it has signed a definitive agreement to acquire PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and rare diseases.

• Centene Completes Acquisition of Apixio

  12/8/2020

   Centene Corporation (NYSE: CNC) today announced that it has completed its acquisition of Apixio, a healthcare analytics company offering Artificial Intelligence (AI) technology solutions. With this transaction, Centene will continue to digitize the administration of healthcare and accelerate innovation and modernization across the enter

• Centene Appoints Brent Layton to Executive Vice President, Markets, Products, International, and Chief Business Development Officer

  12/7/2020

  Centene Corporation announced that Brent Layton has been appointed to Executive Vice President, Markets, Products, International, and Chief Business Development Officer, effective January 1, 2021.

• Centene Provides Format Update Of Virtual 2021 Financial Guidance And Investor Meeting On December 18, 2020

  11/30/2020

  Centene Corporation provided an update on its upcoming 2021 Financial Guidance and Investor Meeting.

• Centene is Proud to Support Rural Healthcare Providers and Members on National Rural Health Day

  11/19/2020

  Centene Corporation announced its support for National Rural Health Day to bring awareness to the unique healthcare challenges faced by providers and individuals who live in rural communities.

• Ambetter's My Health Pays® Helps Members Achieve Millions of Dollars in Value

  11/18/2020

  Ambetter, a health insurance product from Centene Corporation, has helped hundreds of thousands of members take charge of their health through its My Health Pays® rewards program.

• Centene Signs Definitive Agreement to Acquire Apixio

  11/9/2020

  Centene Corporation announced it has signed a definitive agreement to acquire Apixio Inc., a healthcare analytics company offering Artificial Intelligence technology solutions.

• Centene To Participate At Upcoming Conferences

  11/4/2020

  Centene Corporation (NYSE: CNC) announced today it will participate at two virtual conferences this month. On Tuesday, November 10 , at 8:45 a.m. Eastern Standard Time (EST), Centene will participate in a virtual format at the Credit Suisse 29 th Annual Healthcare Conference. A simultaneous live audio webcast is available at: ht

• Centene Corporation Reports Third Quarter 2020 Results

  10/27/2020

  Centene Corporation announced its financial results for the third quarter ended September 30, 2020, reporting diluted earnings per share of $0.97 and Adjusted diluted EPS of $1.26, including the risk corridor, charitable contribution commitment to the Company's foundation and tax benefit highlighted below.

• MHS Health Wisconsin and Samsung Donate Smartphone Devices to Healthcare Providers

  10/21/2020

  Centene and Samsung Electronics America are working together to expand access to telehealth for individuals and families living in underserved communities.

• 'Ohana Health Plan and Samsung Donate Smartphone Devices to Healthcare Providers in Hawaii

  10/12/2020

  Centene and Samsung Electronics America are working together to expand access to telehealth for individuals and families living in rural and underserved communities.

• Centene Expands Medicare Advantage Offerings for 2021

  10/6/2020

  Centene Corporation announced it plans to expand its Medicare Advantage offerings for 2021.

• Centene Corporation Announces Offering of Senior Notes - Sep 23, 2020

  9/23/2020

  Centene Corporation announced that it has commenced an underwritten public offering to sell $2,200,000,000 of senior notes due 2030, subject to market and other conditions.

• Centene Corporation Prices Offering of Senior Notes - Sep 23, 2020

  9/23/2020

  Centene Corporation announced that it has priced its previously announced underwritten public offering of $2,200,000,000 aggregate principal amount of 3.00% senior notes due 2030.